An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing?

• Published in: Journal of diabetes science and technology Vol. 4; no. 2; pp. 357 - 358
• Main Authors: Magnotti, Michael A, Rayfield, Elliot J
• Format: Journal Article
• Language: English
• Published: United States Diabetes Technology Society 01.03.2010
• Subjects: Adult; Caregivers; Child; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - drug therapy; Dose-Response Relationship, Drug; Humans; Hypoglycemia - prevention & control; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - therapeutic use; Insulin - administration & dosage; Insulin - therapeutic use; Original; Self Care; Sensitivity and Specificity
• DOI: 10.1177/193229681000400217
• ISSN: 1932-2968

The HumaPen Luxura HD is an insulin pen device that has the ability to deliver insulin in half-unit increments. This study demonstrates the precision of this pen device using a computer-controlled dose accuracy glide force system. Although one other half-unit pen device is currently on the market, we are not aware of any studies using a similar methodology to verify its precision and accuracy. Clinical experience in treating a select group of adults with diabetes demonstrates the need for such a device. Although there are no outcome studies, this device should help to improve glycemic control and reduce hypoglycemia in such patients. We believe a half-unit insulin pen device is beneficial to more than just the pediatric population, and therefore, this device represents an improvement in present technology.